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ABSTRACT 
The solubility of BCS class II drugs can be enhanced using inclusion complex techniques. Cyclodextrin (CD) and its derivatives are 
promising carrier for the enhancement of aqueous solubility of drugs. The use of the Kneading technique to obtain solid inclusion 
system permitted the formation of a uniform, substantially non-crystalline particle, which increased the solubility and stability of 
Efavirenz (EFV). The present work shows the enhancement of aqueous solubility of BCS class II drug i.e. EFV by making inclusion 
complex with β-CD. The aqueous solubility of EFV is calculated to be 5± 0.003 µg/ml which was increased up to 288.9±0.005 
µg/ml when complexed with β-CD in ratio of 1:1 and 318.5± 0.03 µg/ml in ratio of 1:2. This shows that, the inclusion complex 
technique is a promising way to enhance aqueous solubility. 
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INTRODUCTION: 
The process of drug absorption, bioavailability and 
pharmacokinetic profile of orally administered drug 
substance is highly dependent on factor solubility and 
permeability of that compound in the aqueous medium. 
The study of drug synthesis in pharmaceutical researches 
involves the maximum number of lipophilic drugs which 
have very low solubility rate
1
. Efavirenz (EFV) [(S)-6-
chloro-4-(cyclopropyl ethynyl)-1, 4-dihydro-4-
(trifluoromethyl)-2H-3, 1-benzoxazin-2-one] is a non-
nucleoside reverse transcriptase inhibitor approved for 
the treatment of human immunodeficiency virus type 1 
infection. Efavirenz is a drug with crystalline lypophillic 
solid whose molecular mass is 315.68 and aqueous 
solubility of 9.0μg/ml. This is a class II drug (low 
solubility, high permeability) that is highly permeable, 
poorly soluble drugs often demonstrate poor 
gastrointestinal (GI) absorption due to inadequate drug 
solubility in GI fluids
 2
. 
The solubility of these low soluble drugs is being 
enhanced by various modifications. Cyclodextrins 
(CD’s) are the cyclic oligosaccharides containing 6(α-
CD), 7(β-CD), 8 (γ-CD) α- 1, 4-linked glucopyanose 
units. Each of these CD molecules has the hydrophilic 
property which is helpful in form of hydrophobic guest 
molecule
 3
. 
MATERIALS AND METHODS: 
Materials 
EFV drug provided by Shagun Pharma, Indore. 
Cyclodextrin is used of Loba chemie. 
Methods 
Preparation of Calibration Curve of Drug Efavirenz 
in distilled water: 
The calibration curve was made by finding the 
absorbance of drug dilutions at different concentration in 
the distilled water (solvent).Initially 10 mg of drug was 
dissolved in 10 ml ethanol as a stock solution. Further 
dilutions were prepared having strength of 5, 10, 20, 25, 
30, 40 μg/ml and diluted with distilled water.  
Saturated solubility: 
The saturated solubility of EFV alone in distilled water 
was determined. Sufficient excess amount of EFV was 
added to 10 ml glass vials containing distilled water. The 
vials were shaken mechanically for 12 h on mechanical 
shaker (Lab Hosp, Mumbai) at 37 ± 2°C. The solutions 
were allowed to equilibrate for next 24 h. The solution 
was transferred into eppendorf tubes and centrifuged for 
5 min at 2000 rpm. The supernatants of each vial were 
filtered through 0.45µ membrane filter and analyzed for 
drug content by UV visible spectrophotometer (UV-
1800, Shimadzu, Japan) at 248 nm after appropriate 
dilutions. The study was performed in triplicate.  
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Phase Solubility Studies of Efavirenz with 
Cyclodextrin: 
For the determination of Phase Solubility, different 
concentration of cyclodextrins in Mili Molar 
(1,2,4,6,8,10,12 mM) solution form were prepared in 
10ml distilled water each containing approximate 30mg 
of Efavirenz in each solution. 
Preparations of Inclusion Complex with help of 
Cyclodextrin: 
Basically inclusion complex is the combination of drug 
and the cyclodextrins was prepared by kneading method. 
Kneading Method: 
Initially Cyclodextrin was taken in a mortar with 1 ml of 
50% ethanol to prepare slurry, then Efavirenz in the 
same equimolar quantity of cyclodextrin was taken and 
triturated well for mixing. Small amount of water is then 
added to make slurry having proper consistency and 
kneaded for 15 min, and dried at 50°C for 24 h. The 
resultant dry solid mass was powdered well, passed 
through 60# sieve and stored in a sealed glass 
vials.Inclusion complexes were prepares in the ration of 
1:1 and 1:2 of drug to cyclodextrin ratio 
4
. 
RESULTS AND DISCUSSIONS: 
Calibration curve of drug Efavirenz 
The λmax of EFV in distilled water was calculated as 248 
nm. 
 
Figure 1: Calibration curve of Efavirenz in distilled 
water at 248 nm 
 
Figure 2: Phase solubility study of Efavirenz with β-CD 
(Kst = 190.05 M
-1
)
 
Phase Solubility Studies 
Table 1: Phase Solubility Studies of Efavirenz with Cyclodextrin 
Concentration 
of CD (mM) 
F1 F2 F3 Average 
Concentration 
(in µg/ml) 
Concentration 
(Dilution factor) 
SD 
0.00 0.066 0.06 0.059 0.062 5.698 5.70 0.0030 
1.00 0.708 0.721 0.71 0.713 39.979 39.98 0.0057 
6.00 0.203 0.224 0.211 0.213 13.646 136.46 0.0086 
8.00 0.222 0.236 0.239 0.232 14.681 146.81 0.0074 
10.00 0.249 0.251 0.246 0.249 15.540 155.40 0.0020 
12.00 0.258 0.252 0.248 0.253 15.751 157.51 0.0041 
 
Solubility of drug efavirenz inclusion complex (1:1 
and 1:2) 
The solubility of prepared inclusion complexes in ratio 
1:1 and 1:2 were determined by dissolving complexed 
overnight into the distilled water. It was observed that 
more amount of drug solubilized with the increase in 
amount of cyclodextrin. Following table shows the 
enhancement in the aqueous solubility of efavirenz with 
cyclodextrin complex. 
 
Table 2: The Solubility of Drug Inclusion Complexes (1:1 and 1:2) 
Complex 
Solubility 
     Conc* Amount 
F 1 F 2 F 3 Average Concentration DF (µg/ml) 
Without CD 0.066 0.06 0.059 0.061 5.668 5.668 5.668412 
1:1 1.064 1.057 1.051 1.057 57.797 288.987 288.9878 
1:2 1.129 1.209 1.173 1.170 63.713 318.568 318.5689 
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The results show that the initial solubility of efavirenz in 
water is equal to 5.66 µg/ml whereas, with cyclodextrin 
in the ratio of 1:1 it was observed as 288.9 µg/ml and 
318.56 µg/ml with 1:2 drug: cyclodextrin complex.  
CONCLUSION: 
The solubility of BCS class II drugs can be enhanced 
using inclusion complex techniques. Cyclodextrin and 
its derivatives due to their high aqueous solubility are 
promising carrier for the enhancement of aqueous 
solubility of poorly soluble drugs. The use of the 
Kneading technique to obtain solid inclusion system 
permitted the formation of a uniform, non-crystalline 
particle, which increased the solubility of EFV, and 
provided an increase in the stability of the drug also. 
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